Accordingly, blockade of collagen receptor GPVI and integrin α2β1 on the platelet surface could abolish Hsp47-induced platelet interaction with 4T1, MDA-MB-231 and MCF10A breast cancer cells, indicating an important role of these platelet receptors in EMT (117). The gene discussed is GP6; the disease is breast carcinoma.